Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-24-000052

President CEO and Chairman sold 81,007 shares at an average $133.36 ($10,802,803)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SAYER KEVIN R President CEO and Chairman 2024-03-12 Sale 10b5-1 −29,675 $134.41 $3,988,638 384,858 D: show line 1 in the form
SAYER KEVIN R President CEO and Chairman 2024-03-12 Sale 10b5-1 −12,470 $131.47 $1,639,427 372,388 D: show line 2 in the form
SAYER KEVIN R President CEO and Chairman 2024-03-12 Sale 10b5-1 −14,993 $132.43 $1,985,571 357,395 D: show line 3 in the form
SAYER KEVIN R President CEO and Chairman 2024-03-12 Sale 10b5-1 −20,930 $133.55 $2,795,145 336,465 D: show line 4 in the form
SAYER KEVIN R President CEO and Chairman 2024-03-12 Sale 10b5-1 −2,939 $134.07 $394,023 333,526 D: show line 5 in the form
Open-market sales · 81,007 sh · avg $133.36 · $10,802,803
Loading xslF345X05/edgardoc.xml…